SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001725160-24-000127
Filing Date
2024-05-31
Accepted
2024-05-31 18:27:15
Documents
3
Period of Report
2024-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1717194425.html 4  
1 FORM 4 wk-form4_1717194425.xml 4 3538
2 EX-24 cgallaghernewpoa.htm EX-24 612
3 cgallaghernewpoa001.jpg GRAPHIC 233886
  Complete submission text file 0001725160-24-000127.txt   327961
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address
Gallagher Cam (Reporting) CIK: 0001557832 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39263 | Film No.: 241011391

Mailing Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 801 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Issuer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)